Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $89.5912 (1.06%) ($87.8239 - $89.9765) on Fri. Oct. 12, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.45% (three month average) | RSI | 45 | Latest Price | $89.5912(1.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.6% a day on average for past five trading days. | Weekly Trend | ABBV declines -0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(51%) IVE(49%) SPLV(49%) IWD(48%) | Factors Impacting ABBV price | ABBV will decline at least -0.725% in a week (0% probabilities). VIXM(-14%) TLT(-14%) VXX(-13%) UUP(-11%) DIA(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.725% (StdDev 1.45%) | Hourly BBV | 0 () | Intraday Trend | -0% | | | |
|
Resistance Level | $91.5 | 5 Day Moving Average | $90.87(-1.41%) | 10 Day Moving Average | $91.64(-2.24%) | 20 Day Moving Average | $91.5(-2.09%) | To recent high | -7.2% | To recent low | 3.1% | Market Cap | $158.064b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |